Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of plasma BDNF levels with different stages of Alzheimer's disease: a cross-sectional study.

Neurological research - 1 Mar 2023

Wang Ting, Li Taoran, Hao Shuwen, Han Ying, Cai Yanning

Abstract excerpt

BACKGROUND: Growing evidence shows that the expression of brain-derived neurotrophic factor (BDNF) is altered in the peripheral blood of participants with Alzheimer's disease (AD). It is unclear, however, whether altered BDNF expression is also observed in the early stages of AD. METHODS: In the present study, 138 normal controls (NC), 57 participants with subjective cognitive decline (SCD), and 37 participants...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer Disease
Share to Brain-Derived Neurotrophic Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cognitive Dysfunction

Share to Cross-Sectional Studies

Share to Genotype

Source

Identifiers

PMID: 36453692
DOI: 10.1080/01616412.2022.2129760

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of plasma BDNF levels with different stages of Alzheimer's disease: a cross-sectional study.PMID 36453692Read ↗

Association of plasma brain-derived neurotrophic factor with Alzheimer’s disease and its influencing factors in Chinese elderly populationSemantic proximity Read ↗

Cerebrospinal fluid concentration of brain-derived neurotrophic factor and cognitive function in non-demented subjects.Semantic proximity Read ↗

Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairmentSemantic proximity Read ↗

The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer’s disease: a 9-year follow-up studySemantic proximity Read ↗

Serum brain-derived neurotrophic factor and the risk for dementia: the Framingham Heart Study.Semantic proximity Read ↗

Val66Met polymorphism and BDNF levels in Alzheimer's disease patients in North Indian population.Semantic proximity Read ↗

Brain-Derived Neurotrophic Factor in Alzheimer's Disease: Risk, Mechanisms, and Therapy.Semantic proximity Read ↗

DNA Methylation and Tag SNPs of the BDNF Gene in Conversion of Amnestic Mild Cognitive Impairment into Alzheimer's Disease: A Cross-Sectional Cohort Study.Semantic proximity Read ↗

Gene- and Gender-Related Decrease in Serum BDNF Levels in Alzheimer's Disease.Semantic proximity Read ↗

Characterizing the role of brain derived neurotrophic factor genetic variation in Alzheimer's disease neurodegeneration.Semantic proximity Read ↗

APOE and BDNF polymorphisms moderate amyloid β-related cognitive decline in preclinical Alzheimer's disease.Semantic proximity Read ↗

Role of BDNF Val66Met functional polymorphism in Alzheimer's disease-related depression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.